T. Rowe Price Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
2021
Q3
$210K Buy
2021
Q2
$157K Buy
2021
Q1
$166K Buy
2020
Q4
Sell
2020
Q3
$168K Buy
2020
Q2
$203K Buy
2020
Q1
$120K Buy
2018
Q4
Sell
2018
Q3
$282K Buy
2018
Q2
$294K Buy
2018
Q1
$254K Buy
2017
Q4
$282K Buy